Similar Papers

Paper Title
Journal
Date
Author
Abstract 4982: Anti-mCTLA-4 treatment results in early and late immune response effects in a murine model of colorectal carcinoma
...
-
, et. al. ...
01 Jul 2019
Abstract 4982: Anti-mCTLA-4 treatment results in early and late immune response effects in a murine model of colorectal carcinoma
David W Draper ... Scott Wise
Cancer Research | VOL. 79
David W Draper, et. al.David W Draper ... Scott Wise
01 Jul 2019
The Overlapping Roles of Antimicrobial Peptides and Complement in Recruitment and Activation of Tumor-Associated Inflammatory Cells
Izzat A M Al-Rayahi ... Raghad H H Sanyi
Frontiers in Immunology | VOL. 6
Izzat A M Al-Rayahi, et. al.Izzat A M Al-Rayahi ... Raghad H H Sanyi
22 Jan 2015
CCR5 Deficiency Aggravates Crescentic Glomerulonephritis in Mice
Jan-Eric Turner ... Anett Peters
The Journal of Immunology | VOL. 181
Jan-Eric Turner, et. al.Jan-Eric Turner ... Anett Peters
20 Oct 2008
View more papers

More From: Molecular Cancer

Paper Title
Journal
Date
Author
CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance
Xuemeng Xu ... Qianjin Liao
Molecular Cancer | VOL. 24
Xuemeng Xu, et. al.Xuemeng Xu ... Qianjin Liao
31 Jan 2025
lncRNAs: the unexpected link between protein synthesis and cancer adaptation
Mila Gugnoni ... Alessia Ciarrocchi
Molecular Cancer | VOL. 24
Mila Gugnoni, et. al.Mila Gugnoni ... Alessia Ciarrocchi
31 Jan 2025
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment
Zhenyun Yang ... Minshan Chen
Molecular Cancer | VOL. 24
Zhenyun Yang, et. al.Zhenyun Yang ... Minshan Chen
31 Jan 2025
Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Claire Corcoran ... Lorraine O'Driscoll
Molecular Cancer | VOL. 24
Claire Corcoran, et. al.Claire Corcoran ... Lorraine O'Driscoll
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.